captopril has been researched along with amyloid beta-peptides in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Komano, H; Liu, J; Liu, S; Maeda, T; Michikawa, M; Oba, R; Satoh, Y; Watanabe, A; Zou, K | 1 |
Hiraga, S; Komano, H; Liu, J; Liu, S; Maeda, T; Michikawa, M; Takahashi, S; Tanabe, C; Terayama, Y; Watanabe, A; Zou, K | 1 |
2 other study(ies) available for captopril and amyloid beta-peptides
Article | Year |
---|---|
Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme.
Topics: Amyloid beta-Peptides; Angiotensins; Animals; Blotting, Western; Captopril; Catalytic Domain; Chlorocebus aethiops; COS Cells; Enalaprilat; Glycosylation; Humans; Mutation; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2009 |
Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Brain; Captopril; Case-Control Studies; Disease Progression; Humans; Mice; Mice, Transgenic; Mutation; Peptide Fragments; Peptidyl-Dipeptidase A; Presenilins | 2013 |